Chain Reaction Innovations Cohort 2027: $115,000-a-Year Deep-Tech Fellowship at Argonne

Chain Reaction Innovations Cohort 2027: $115,000-a-Year Deep-Tech Fellowship at Argonne

Chain Reaction Innovations (CRI) is opening its 2027 cohort to technical founders who need more than a conventional accelerator can provide. The two-year fellowship embeds selected innovators at Argonne National Laboratory, where they can develop an early-stage science or energy technology with access to national-laboratory researchers, equipment, facilities, and business mentors. The current program announcement lists a stipend of $115,000 per year for two years, healthcare benefits, and non-dilutive funding to help de-risk and scale the technology. Argonne and the U.S. Department of Energy do not take an equity stake in participating startups.

The Cohort 2027 application window opens on September 15, 2026, and closes at 5 p.m. Central Time on October 30, 2026. This is a strong fit for a founder with serious technical evidence and a difficult development problem, not for a general software startup seeking a short business boot camp. CRI expects its innovators to work in residence at Argonne and to move to the Chicago area if they do not already live nearby.

CRI at a glance

The $115,000 figure is the published annual stipend for the 2027 recruitment announcement. The program also describes healthcare benefits and non-dilutive funding, but it does not publish a single combined award value or a universal dollar ceiling for the technology-development support on the application page. Treat the stipend as the confirmed personal support and ask CRI about the funding structure for laboratory work if your plan depends on a specific equipment, testing, or subcontracting budget.

What the fellowship provides

CRI is designed around the gap between a promising technical concept and a pre-commercial prototype. That gap can be especially hard for a small company: specialized equipment is expensive, validation takes time, technical risks are difficult to explain to investors, and a founder may have to divide attention between experiments and the business. CRI addresses those constraints by placing the innovator inside Argonne for a sustained period rather than offering a short series of workshops.

The fellowship support includes the annual stipend, healthcare benefits, and a two-year runway to concentrate on the technology. CRI’s program page also describes provisions such as a travel allowance, dedicated laboratory and office space, use of laboratory equipment, assistance with R&D, and support obtaining additional project funds. The exact terms should be confirmed in the offer and associated fellowship documents; the public page is clear about the categories of support but does not promise that every project receives the same travel or project budget.

The technical environment is a major part of the opportunity. Argonne gives CRI innovators access to researchers, specialized facilities, advanced imaging, high-performance computing, fabrication and scale-up capabilities, and testing and validation resources. That access can shorten the time needed to identify material failures, model performance, test durability, or determine whether a prototype is ready for a commercial conversation. The relevant question is not whether Argonne is prestigious. It is whether a specific Argonne capability would answer a technical question that your startup cannot answer efficiently on its own.

CRI also connects innovators with business experts, investors, mentors, corporate partners, and organizations in the Chicago innovation ecosystem. The program describes help with business strategy, market research, long-term financing, and commercial partnerships. Those connections are useful, but they do not replace a credible technical plan or a founder who understands the customer and adoption path.

Who the 2027 cohort is for

The official FAQ defines a narrow founder profile. Applicants must be U.S. citizens or lawful permanent residents. They must have at least five years of R&D technology experience and be first-time technical founders. A founder does not need to have incorporated a company at the time of application, but an existing startup affiliated with an applicant must be incorporated in the United States. If selected, the business must be structured as a C corporation rather than an LLC.

CRI also limits the amount of private funding an applicant may have raised: no more than $2 million in private-sector funding at the time of application. This is not a grant for an established, heavily capitalized company that already has the resources to build the relevant prototype. The program is intended for a technically capable founder who is still early enough to benefit from a national-laboratory runway and from structured commercialization support.

The technology must support the DOE mission and address a complex scientific challenge that needs a development period of about two years to reach a pre-commercial prototype. A product can be commercially ambitious, but it should not be presented as a normal consumer or software venture with only a light technical component. The public criteria point toward hard problems involving science, engineering, materials, energy, manufacturing, or related technologies where laboratory development and validation are central.

In practical terms, the best-fit applicant can explain three things clearly: what has already been demonstrated, what remains technically uncertain, and why access to Argonne would materially change the pace or quality of development. A polished pitch without technical evidence is weak. So is a technically interesting project with no plausible path to a user, market, public benefit, or strategic need.

Technology areas in the 2027 call

CRI’s current priority list is broad but concrete. It includes domestic critical-mineral extraction, processing and recycling; manufacturing and scale-up for energy applications; industrial competitiveness; building technologies; energy generation and power management; advanced transportation; fuels and feedstocks; dual-use battery technologies; water power and energy-water systems; data-center energy technologies; AI and advanced computing; and platforms that advance scientific research.

The list also names transmission and distribution, grid information security, grid energy storage, nuclear energy, oil and gas, coal, geothermal, cyber and energy security, and other technologies that further DOE’s mission of addressing energy and nuclear challenges. The inclusion of a technology on the list does not guarantee fit. Your application still needs to show a meaningful connection to DOE priorities, Argonne capabilities, and the CRI model.

For a project in an adjacent field, build the connection from the technical problem rather than forcing a slogan into the first paragraph. For example, explain how a materials innovation affects manufacturing scale-up, how a data-center technology changes energy use, or how a platform enables a scientific measurement that is currently too slow or expensive. The application should help reviewers see both the technical mechanism and the mission relevance.

How to apply

CRI says the 2027 application must be submitted through its online portal. The program will not review a PDF sent by email. Before the window opens, the Apply page offers a pre-application option for reminders and says that a courtesy PDF template for Cohort 2027 will be made available. Use that template, once published, as a planning worksheet rather than as the submission route.

The public page does not yet publish the complete 2027 application PDF, so some exact prompts and upload fields are not confirmed at this date. That is important: do not assume that an old CRI application, a generic accelerator form, or a partner’s summary contains the complete current requirements. Review the live portal as soon as applications open, then reconcile every field with the current instructions.

The selection process is competitive. CRI says applicants are reviewed by Argonne and selected by a federal official from DOE. The FAQ identifies evaluation areas including alignment with DOE priorities, alignment with Argonne capabilities, fit with the CRI model, and the strength of the market-potential framework. It also says selected candidates must later upload a resume and transcripts or other official degree documentation through ORISE’s Zintellect applicant system, with the offer contingent on eligibility verification.

Because the program reviews an individual founder, make the application readable as both a technical assessment and a founder assessment. Explain your role in the work, what you personally know how to do, and where you need Argonne or outside partners. If several people from one startup want to apply, the FAQ says each person may submit a separate individual application, but only one person will be chosen for the program.

Timeline and preparation plan

The live 2027 schedule is short enough that preparation should begin before the portal opens.

1. Before September 15: Confirm citizenship or permanent-resident status, review the five-year R&D experience requirement, map your current private funding, and check whether your company structure can meet the C-corporation requirement if selected.
2. September 15: Open the online application and copy the current questions into a private working document. Do not email a completed PDF in place of the portal submission.
3. September 18: Use the first listed CRI office-hours session for questions about fit, the application, or technical alignment if needed.
4. September 29, 2–3 p.m. CT: Attend the CRI informational webinar. Registration is suggested but not required according to the official Apply page.
5. October 2 and October 16: Use the later office-hour sessions to resolve questions that emerged while drafting.
6. October 30, 5 p.m. CT: Submit the complete application through the online portal. The program also lists office hours on October 30, but do not plan to use the final hours as a substitute for an early submission.

CRI says cohorts are selected in late spring or early summer, subject to DOE funding. The current public information does not state a fixed 2027 start date. If you reach the later stages, confirm the expected start, Argonne access process, relocation timing, and employment or fellowship documentation directly with CRI.

Materials to prepare

The exact portal checklist is not yet confirmed for the 2027 cycle, but the official pages establish the evidence you should be ready to organize. Start with a concise technical record: prototypes, test results, experimental methods, relevant publications or patents, performance measurements, failure analysis, and a description of what remains unresolved. Use dates, comparison points, and units where available. “Promising” is less useful than a measured result and a clear statement of its limitations.

Prepare a founder résumé that emphasizes hands-on R&D, technology leadership, commercialization decisions, and work that demonstrates persistence through technical uncertainty. Gather transcripts or official degree evidence even though the FAQ identifies those as post-selection verification materials. If your experience is equivalent to a doctorate rather than represented by one, document the five or more years of relevant R&D in a way that a reviewer can verify.

Build a short Argonne capability map. Identify the facility, instrument, expertise, or research relationship that would address each major technical risk. Then describe the work you would do during the first six months, the evidence you expect to produce, and the decision that evidence would enable. Include a market-potential framework: who needs the technology, what problem it solves, what alternatives exist, what adoption barrier matters most, and what milestone would make a customer, partner, or investor take the next conversation seriously.

Keep proprietary information out of the application. CRI’s FAQ says applications are reviewed by scientific and industry experts inside and outside Argonne and asks applicants not to reveal confidential or proprietary information. Use non-confidential descriptions, mark public evidence clearly, and speak with CRI if the application seems to require disclosure of protected information.

What reviewers need to believe

Reviewers need to see a coherent chain from technology to impact. First, the scientific or engineering problem must be real and difficult enough to justify a two-year lab-embedded program. Second, the proposed work must match capabilities that CRI and Argonne can actually provide. Third, the founder must have the technical judgment and entrepreneurial discipline to turn new evidence into decisions.

Make the current state of the technology easy to locate. A useful structure is: demonstrated result, remaining risk, experiment or development step, success threshold, and consequence for the product. This gives technical reviewers enough substance to evaluate feasibility while giving business reviewers a reason to believe the work changes the commercial path.

Be equally clear about what CRI cannot solve. The program can provide facilities, mentors, and funding, but it cannot create demand for a technology with no defined user. It can help a founder investigate a difficult market, but it cannot make an immature product ready for deployment without milestones. It can introduce investors and partners, but introductions are more valuable when the founder knows exactly what evidence or relationship is needed next.

Common mistakes to avoid

The first mistake is applying as if CRI were a generic startup accelerator. The program is built for science- and energy-based technologies with substantial R&D needs. A broad growth plan without a specific technical bottleneck will not show why Argonne is necessary.

The second is overlooking the residency requirement. This is an in-person fellowship at Argonne, not a remote award. Plan for a Chicago-area move, daily work arrangements, and the practical effect on your company and household before you submit.

The third is ignoring the company-formation and funding rules. You may not need a company on the application date, but selection requires an incorporated business structured as a C corporation. Existing companies must be incorporated in the United States, and private-sector funding must stay within the published limit. Ask CRI before applying if your ownership, investment, or entity situation is unusual.

The fourth is treating non-dilutive funding as unlimited project capital. CRI’s public page confirms that non-dilutive support is part of the program, but it does not publish a universal amount. Describe a disciplined use of resources and separate the work that needs Argonne from the work that needs outside financing.

Finally, do not put trade secrets in a form that will be reviewed by people outside your organization. A strong application can communicate the problem, method, evidence, and advantage without exposing the details needed to copy the invention.

Frequently asked questions

Is the 2027 application open now?

Not yet as of the published schedule for this page. Applications open on September 15, 2026, and close at 5 p.m. CT on October 30, 2026. The CRI Apply page offers a pre-application reminder before the portal opens.

Is the $115,000 stipend a grant to the startup?

The official announcement describes it as an annual stipend for selected innovators. CRI separately describes non-dilutive funding for technology de-risking and development. These are different parts of the support package; confirm the project-funding mechanics in the current application and any offer documents.

Can an LLC apply?

An applicant does not need to have incorporated a company at the time of application. If selected, however, the FAQ says the technology business must be structured as a C corporation rather than an LLC. Existing affiliated startups must be incorporated in the United States.

Can a founder with more than five years of experience apply?

Yes, provided the applicant still fits the first-time-founder and funding rules. The official FAQ sets a minimum of five years of R&D technology experience; it does not describe five years as a maximum.

Do I have to move to Chicago?

Yes. CRI says innovators must be in residence at Argonne, so anyone outside the Chicago metro area should expect to relocate. Confirm timing and practical arrangements with CRI if you advance.

Does Argonne take equity in the startup?

No. The official Apply page states that neither Argonne nor DOE takes an equity stake in CRI startups. Other legal, intellectual-property, conflict-of-interest, and CRADA terms still apply.

What happens to intellectual property developed with Argonne?

Selected innovators work with Argonne through a Cooperative Research and Development Agreement. CRI says the CRADA includes non-negotiable confidentiality language, and its FAQ describes an IP Management Plan that must be reviewed before the R&D phase. Read those terms carefully before accepting an offer.

Official links and next steps

Start with the official CRI application page, which controls the live dates, portal route, webinar, office hours, funding summary, and technology areas. Read the CRI FAQ for the detailed founder, funding, residency, company, intellectual-property, and site-access rules. The CRI program page explains how laboratory access, technical support, and business mentorship fit together. For the current 2027 announcement, see CRI to Open Recruitment for Cohort 2027.

Before September 15, prepare your non-confidential evidence file, identify the Argonne capabilities that match your risks, check the residency and C-corporation requirements, and reserve time for a complete portal submission. Recheck the live page on the day you apply because the 2027 application template and any portal instructions may add details that were not published in advance.